שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - omeprazolum - compresse rivestite con film - omeprazolum 20 mg, betadexum, lactosum monohydricum 39.0 mg, maydis amylum, carboxymethylamylum natricum a corresp. natrium 0.924 mg, magnesii stearas, hypromellosi phthalas, monoglyceriderorum diacetylates, e 171, e 172 (nigrum), pro compresso obducto. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - omeprazolum - compresse rivestite con film - omeprazolum 40 mg, betadexum, lactosum monohydricum 151.0 mg, carboxymethylamylum natricum a corresp. natrium 0.840 mg, magnesii stearas, hypromellosi phthalas, monoglyceriderorum diacetylates, e 171, e 172 (nigrum), pro compresso obducto. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - omeprazolum - compresse rivestite con film - omeprazolum 10 mg, excipiens pro compresso obducto. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - omeprazolum - fimtabletten - omeprazolum 20 mg, excipiens pro compresso obducto. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - omeprazolum - compresse rivestite con film - omeprazolum 40 mg, excipiens pro compresso obducto. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

drossapharm ag - omeprazolum - compresse rivestite con film - omeprazolum 10 mg, betadexum, lactosum monohydricum 19.5 mg, maydis amylum, carboxymethylamylum natricum a corresp. natrium 0.5 mg, magnesii stearas, hypromellosi phthalas, monoglyceriderorum diacetylates, e 171, e 172 (nigrum), pro compresso obducto. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

drossapharm ag - omeprazolum - compresse rivestite con film - omeprazolum 20 mg, betadexum, lactosum monohydricum 39.0 mg, maydis amylum, carboxymethylamylum natricum a corresp. natrium 0.9 mg, magnesii stearas, hypromellosi phthalas, monoglyceriderorum diacetylates, e 171, e 172 (nigrum), pro compresso obducto. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

drossapharm ag - omeprazolum - compresse rivestite con film - omeprazolum 40 mg, betadexum, lactosum monohydricum 151.0 mg, carboxymethylamylum natricum a corresp. natrium 0.8 mg, magnesii stearas, hypromellosi phthalas, monoglyceriderorum diacetylates, e 171, e 172 (nigrum), pro compresso obducto. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - omeprazolum - capsule - omeprazolum 40 mg, sacchari sphaerae cum saccharum max. 79.76 mg et maydis amylum, hypromellosum, natrii laurilsulfas, magnesii oxidum ponderosum, povidonum k 25, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, kapselhülle: gelatina, aqua purificata, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro capsula corresp. natrium 0.12 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - omeprazolum - capsule - omeprazolum 10 mg, sacchari sphaerae cum saccharum max. 19.94 mg et maydis amylum, hypromellosum, natrii laurilsulfas, magnesii oxidum ponderosum, povidonum k 25, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, kapselhülle: gelatina, aqua purificata, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro capsula corresp. natrium 0.03 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika